Global EGFR-TKI for Advanced NSCLC Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global EGFR-TKI for Advanced NSCLC Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Gefitinib
  • 1.2.3 Erlotinib
  • 1.2.4 Afatinib
• 1.3 Market by Application
  • 1.3.1 Global EGFR-TKI for Advanced NSCLC Market Share by Application: 2020 VS 2026
  • 1.3.2 Combination Therapy
  • 1.3.3 Mono Therapy
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global EGFR-TKI for Advanced NSCLC Market Perspective (2015-2026)
• 2.2 Global EGFR-TKI for Advanced NSCLC Growth Trends by Regions
  • 2.2.1 EGFR-TKI for Advanced NSCLC Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 EGFR-TKI for Advanced NSCLC Historic Market Share by Regions (2015-2020)
  • 2.2.3 EGFR-TKI for Advanced NSCLC Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top EGFR-TKI for Advanced NSCLC Players by Market Size
  • 3.1.1 Global Top EGFR-TKI for Advanced NSCLC Players by Revenue (2015-2020)
  • 3.1.2 Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Players (2015-2020)
• 3.2 Global EGFR-TKI for Advanced NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by EGFR-TKI for Advanced NSCLC Revenue
• 3.4 Global EGFR-TKI for Advanced NSCLC Market Concentration Ratio
  • 3.4.1 Global EGFR-TKI for Advanced NSCLC Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by EGFR-TKI for Advanced NSCLC Revenue in 2019
• 3.5 Key Players EGFR-TKI for Advanced NSCLC Area Served
• 3.6 Key Players EGFR-TKI for Advanced NSCLC Product Solution and Service
• 3.7 Date of Enter into EGFR-TKI for Advanced NSCLC Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 EGFR-TKI for Advanced NSCLC Breakdown Data by Type (2015-2026)

• 4.1 Global EGFR-TKI for Advanced NSCLC Historic Market Size by Type (2015-2020)
• 4.2 Global EGFR-TKI for Advanced NSCLC Forecasted Market Size by Type (2021-2026)

5 EGFR-TKI for Advanced NSCLC Breakdown Data by Application (2015-2026)

• 5.1 Global EGFR-TKI for Advanced NSCLC Historic Market Size by Application (2015-2020)
• 5.2 Global EGFR-TKI for Advanced NSCLC Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
• 6.2 North America EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
• 6.3 North America EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
• 6.4 North America EGFR-TKI for Advanced NSCLC Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
• 7.2 Europe EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
• 7.3 Europe EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
• 7.4 Europe EGFR-TKI for Advanced NSCLC Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
• 8.2 China EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
• 8.3 China EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
• 8.4 China EGFR-TKI for Advanced NSCLC Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
• 9.2 Japan EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
• 9.3 Japan EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
• 9.4 Japan EGFR-TKI for Advanced NSCLC Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia EGFR-TKI for Advanced NSCLC Market Size (2015-2026)
• 10.2 Southeast Asia EGFR-TKI for Advanced NSCLC Market Size by Type (2015-2020)
• 10.3 Southeast Asia EGFR-TKI for Advanced NSCLC Market Size by Application (2015-2020)
• 10.4 Southeast Asia EGFR-TKI for Advanced NSCLC Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 Henan DaKen Chemical
  • 11.1.1 Henan DaKen Chemical Company Details
  • 11.1.2 Henan DaKen Chemical Business Overview
  • 11.1.3 Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Introduction
  • 11.1.4 Henan DaKen Chemical Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020))
  • 11.1.5 Henan DaKen Chemical Recent Development
• 11.2 Capot Chemical Co.,Ltd.
  • 11.2.1 Capot Chemical Co.,Ltd. Company Details
  • 11.2.2 Capot Chemical Co.,Ltd. Business Overview
  • 11.2.3 Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Introduction
  • 11.2.4 Capot Chemical Co.,Ltd. Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
  • 11.2.5 Capot Chemical Co.,Ltd. Recent Development
• 11.3 Chemwill Asia Co.,Ltd.
  • 11.3.1 Chemwill Asia Co.,Ltd. Company Details
  • 11.3.2 Chemwill Asia Co.,Ltd. Business Overview
  • 11.3.3 Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Introduction
  • 11.3.4 Chemwill Asia Co.,Ltd. Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
  • 11.3.5 Chemwill Asia Co.,Ltd. Recent Development
• 11.4 MSN Labs
  • 11.4.1 MSN Labs Company Details
  • 11.4.2 MSN Labs Business Overview
  • 11.4.3 MSN Labs EGFR-TKI for Advanced NSCLC Introduction
  • 11.4.4 MSN Labs Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
  • 11.4.5 MSN Labs Recent Development
• 11.5 Sun Pharma
  • 11.5.1 Sun Pharma Company Details
  • 11.5.2 Sun Pharma Business Overview
  • 11.5.3 Sun Pharma EGFR-TKI for Advanced NSCLC Introduction
  • 11.5.4 Sun Pharma Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
  • 11.5.5 Sun Pharma Recent Development
• 11.6 Amadis Chemical
  • 11.6.1 Amadis Chemical Company Details
  • 11.6.2 Amadis Chemical Business Overview
  • 11.6.3 Amadis Chemical EGFR-TKI for Advanced NSCLC Introduction
  • 11.6.4 Amadis Chemical Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
  • 11.6.5 Amadis Chemical Recent Development
• 11.7 Chongqing Chemdad Co., Ltd
  • 11.7.1 Chongqing Chemdad Co., Ltd Company Details
  • 11.7.2 Chongqing Chemdad Co., Ltd Business Overview
  • 11.7.3 Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Introduction
  • 11.7.4 Chongqing Chemdad Co., Ltd Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
  • 11.7.5 Chongqing Chemdad Co., Ltd Recent Development
• 11.8 Mylan
  • 11.8.1 Mylan Company Details
  • 11.8.2 Mylan Business Overview
  • 11.8.3 Mylan EGFR-TKI for Advanced NSCLC Introduction
  • 11.8.4 Mylan Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
  • 11.8.5 Mylan Recent Development
• 11.9 Alchem Pharmtech,Inc.
  • 11.9.1 Alchem Pharmtech,Inc. Company Details
  • 11.9.2 Alchem Pharmtech,Inc. Business Overview
  • 11.9.3 Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Introduction
  • 11.9.4 Alchem Pharmtech,Inc. Revenue in EGFR-TKI for Advanced NSCLC Business (2015-2020)
  • 11.9.5 Alchem Pharmtech,Inc. Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer